Where is the door? Understanding investment exits in the post-COVID environment

This virtual event will take place on 19 November 2020, at 17.00 GMT

Despite the COVID-19 pandemic and its associated uncertainty, exit activity remains strong. The IPO market is busy, with new trends emerging with alternative paths to IPO, and the M&A market has more recently resumed in earnest.

Prior to lockdown, exit timelines for the rest of 2020 were largely focused on working around the upcoming U.S. elections. The focus has now shifted to the duration and impact of the pandemic, and when for a particular company is its business at a point where it can consider an exit.
In evaluating the types of exit that may be right for your company, our presenters will discuss some key considerations, challenges, and strategies that may affect your decisions.


  • Michael Anstey, Partner at CIC specialising in life sciences investments
  • Adam Kostyál, Board Member at NASDAQ STOCKHOLM AB
  • Alexandra Richardson, Partner, Corporate Technology at Taylor Wessing
  • Michael Labriola, Partner at Wilson Sonsini Goodrich & Rosati (WSGR)
  • Matthew Gehl, Managing Director - Head of EMEA Technology Banking at JPMorgan Chase & Co

Presentation materials from Adam Kostyál, Head of European Listings, NASDAQ. Adam provided a comparison of US versus Europe exchanges for Tech and Healthcare companies. Read the materials.